TAIFLEX Scientific Co., Ltd.(TW:8039)
NT$227.00+12.50 (+5.83%)
TW:8039
TAIFLEX Scientific Co., Ltd. financials statements
NT$227.00
At close:+12.50 (+5.83%)
TAIFLEX Scientific Co., Ltd. (8039) Ratios
TAIFLEX Scientific Co., Ltd. Ratios
TW:8039's free cash flow for Q3 2026 was NT$-95.79M. For the 2026 fiscal year, TW:8039's free cash flow was decreased by NT$-154.16M and operating cash flow was NT$58.38M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.94 | 3.11 | 1.80 | 3.82 | 3.26 |
| Quick Ratio | 2.36 | 2.52 | 1.45 | 2.97 | 2.62 |
| Cash Ratio | 0.91 | 1.02 | 0.48 | 1.09 | 1.11 |
| Solvency Ratio | 0.28 | 0.29 | 0.18 | 0.24 | 0.18 |
| Operating Cash Flow Ratio | 0.22 | 0.50 | 0.31 | 0.55 | 0.08 |
| Short-Term Operating Cash Flow Coverage | 1.57 | 3.51 | 0.59 | 3.52 | 0.27 |
| Net Current Asset Value | NT$ 5.44B | NT$ 4.91B | NT$ 2.41B | NT$ 3.12B | NT$ 3.40B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.06 | 0.08 | 0.21 | 0.22 | 0.26 |
| Debt-to-Equity Ratio | 0.08 | 0.11 | 0.35 | 0.35 | 0.48 |
| Debt-to-Capital Ratio | 0.08 | 0.10 | 0.26 | 0.26 | 0.32 |
| Long-Term Debt-to-Capital Ratio | 0.02 | 0.05 | 0.04 | 0.22 | 0.25 |
| Financial Leverage Ratio | 1.36 | 1.36 | 1.63 | 1.62 | 1.81 |
| Debt Service Coverage Ratio | 2.05 | 2.51 | 0.39 | 3.24 | 1.35 |
| Interest Coverage Ratio | 22.44 | 22.05 | 15.11 | 26.09 | 46.02 |
| Debt to Market Cap | 0.03 | 0.09 | 0.24 | 0.30 | 0.36 |
| Interest Debt Per Share | 3.72 | 5.23 | 12.82 | 13.49 | 17.90 |
| Net Debt to EBITDA | -1.86 | -1.34 | 0.83 | 0.39 | 0.33 |
| Profitability Margins | |||||
| Gross Profit Margin | 18.27% | 21.51% | 21.98% | 23.84% | 23.38% |
| EBIT Margin | 4.78% | 7.37% | 6.32% | 10.46% | 10.22% |
| EBITDA Margin | 9.93% | 12.70% | 11.95% | 15.48% | 14.40% |
| Operating Profit Margin | 4.78% | 6.95% | 6.02% | 10.53% | 10.18% |
| Pretax Profit Margin | 5.79% | 7.05% | 5.92% | 10.06% | 10.00% |
| Net Profit Margin | 5.04% | 5.96% | 5.19% | 8.03% | 7.81% |
| Continuous Operations Profit Margin | 4.95% | 5.36% | 4.43% | 7.95% | 8.00% |
| Net Income Per EBT | 87.05% | 84.56% | 87.70% | 79.84% | 78.09% |
| EBT Per EBIT | 121.30% | 101.42% | 98.32% | 95.51% | 98.29% |
| Return on Assets (ROA) | 3.62% | 4.08% | 3.25% | 5.45% | 5.22% |
| Return on Equity (ROE) | 4.91% | 5.57% | 5.30% | 8.86% | 9.46% |
| Return on Capital Employed (ROCE) | 4.37% | 5.91% | 5.49% | 8.52% | 8.59% |
| Return on Invested Capital (ROIC) | 3.59% | 4.33% | 3.30% | 6.51% | 6.32% |
| Return on Tangible Assets | 3.66% | 4.12% | 3.28% | 5.52% | 5.28% |
| Earnings Yield | 2.48% | 5.63% | 4.12% | 8.50% | 7.74% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.43 | 2.56 | 2.11 | 2.34 | 2.34 |
| Payables Turnover | 6.16 | 5.86 | 6.10 | 8.83 | 5.63 |
| Inventory Turnover | 4.78 | 4.72 | 4.51 | 3.75 | 3.86 |
| Fixed Asset Turnover | 2.19 | 1.98 | 1.67 | 2.03 | 2.52 |
| Asset Turnover | 0.72 | 0.68 | 0.63 | 0.68 | 0.67 |
| Working Capital Turnover Ratio | 1.76 | 2.16 | 1.79 | 1.40 | 1.65 |
| Cash Conversion Cycle | 167.59 | 157.55 | 194.34 | 212.05 | 185.63 |
| Days of Sales Outstanding | 150.50 | 142.57 | 173.26 | 156.10 | 155.78 |
| Days of Inventory Outstanding | 76.36 | 77.32 | 80.92 | 97.29 | 94.65 |
| Days of Payables Outstanding | 59.27 | 62.34 | 59.83 | 41.34 | 64.80 |
| Operating Cycle | 226.86 | 219.89 | 254.18 | 253.39 | 250.43 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.78 | 6.05 | 5.80 | 5.46 | 1.09 |
| Free Cash Flow Per Share | 0.43 | 3.07 | 1.17 | 0.77 | -1.50 |
| Dividend Paid and CapEx Coverage Ratio | 0.57 | 1.56 | 0.83 | 0.76 | 0.21 |
| Capital Expenditure Coverage Ratio | 1.18 | 2.03 | 1.25 | 1.16 | 0.42 |
| Operating Cash Flow Coverage Ratio | 0.76 | 1.19 | 0.46 | 0.41 | 0.06 |
| Operating Cash Flow to Sales Ratio | 0.07 | 0.14 | 0.16 | 0.13 | 0.02 |
| Free Cash Flow Yield | 0.50% | 6.84% | 2.49% | 1.95% | -3.30% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 41.16 | 17.73 | 23.45 | 11.76 | 12.94 |
| Price-to-Sales (P/S) Ratio | 2.04 | 1.06 | 1.26 | 0.94 | 1.01 |
| Price-to-Book (P/B) Ratio | 1.98 | 0.99 | 1.29 | 1.04 | 1.22 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 198.17 | 14.63 | 40.22 | 51.39 | -30.32 |
| Price-to-Operating Cash Flow Ratio | 30.70 | 7.41 | 8.08 | 7.21 | 41.61 |
| Price-to-Earnings Growth (PEG) Ratio | -2.26 | 0.67 | -0.58 | -2.58 | -2.52 |
| Enterprise Value Multiple | 18.66 | 7.00 | 11.39 | 6.48 | 7.35 |
| Enterprise Value | 19.65B | 8.83B | 11.09B | 8.76B | 9.95B |
| EV to EBITDA | 18.66 | 7.00 | 11.39 | 6.48 | 7.35 |
| EV to Sales | 1.85 | 0.89 | 1.36 | 1.00 | 1.06 |
| EV to Free Cash Flow | 180.22 | 12.28 | 43.40 | 54.64 | -31.76 |
| EV to Operating Cash Flow | 27.92 | 6.22 | 8.72 | 7.67 | 43.59 |
| Tangible Book Value Per Share | 42.51 | 44.83 | 36.13 | 37.72 | 37.06 |
| Shareholders’ Equity Per Share | 42.96 | 45.35 | 36.45 | 37.82 | 37.13 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.15 | 0.24 | 0.25 | 0.21 | 0.21 |
| Revenue Per Share | 41.83 | 42.34 | 37.19 | 41.71 | 44.97 |
| Net Income Per Share | 2.11 | 2.53 | 1.93 | 3.35 | 3.51 |
| Tax Burden | 0.87 | 0.85 | 0.88 | 0.80 | 0.78 |
| Interest Burden | 1.21 | 0.96 | 0.94 | 0.96 | 0.98 |
| Research & Development to Revenue | 0.04 | 0.04 | 0.04 | 0.05 | 0.03 |
| SG&A to Revenue | 0.10 | 0.11 | 0.11 | 0.12 | 0.10 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.32 | 2.03 | 2.64 | 1.30 | 0.24 |
Currency in TWD
